Which Prescription Weight Loss Drugs Give Accountability and Structure? (October 2026)

01 · The verdict

Which prescription option gives structure?

A once-weekly injection reviewed monthly by a prescriber gives a fixed routine and regular check-ins. Mounjaro is a once-weekly prescription medicine made by Eli Lilly, licensed in the UK for weight management in adults, supplied as a pre-filled KwikPen in six strengths from 2.5mg to 15mg.¹ One injection, same day each week, is easy to build a habit around and easy to report on at a review.

Accountability is a separate thing from the drug. The medicine reduces hunger and helps you feel full sooner; the structure comes from the dose schedule, the check-ins and the tracking you do yourself. For wider context, see our guide to prescription weight loss injections.

If you want the widest set of options in one place, our weight loss treatments overview lists them.

02 · Cost

What structured treatment costs with us

The Mounjaro pen starts at £169.99 per month for the 2.5mg starter at standard price. A new customer gets £40 off their first order at any dose with code FIRST40, so your first 2.5mg pen costs £129.99. Switching to us at 15mg? Your first order is £289.99. After that, every later order is £25 off the standard price (code DOSE25).

The consultation is free and the price shown is the price paid, with no hidden fees. Aftercare is part of the service: ongoing monthly reviews, dose-titration and follow-up assessments by the prescribing team, and side-effect support. Repeat orders re-check suitability and nothing auto-ships, so you are asked how you are getting on before each new pen is supplied. That check is the accountability mechanism most people mean.

At standard prices, a first year costs £2,711.88 if you stay on 5mg after your 2.5mg starting pen, up to £3,599.88 if you step up through every dose to 15mg. A new customer's first order is £40 less and every later order £25 less. Pay by Visa or Mastercard, Klarna or pay-monthly options; there are no subscriptions.

03 · Ordering

How ordering works

Ordering takes three steps and starts with a free online consultation. First, you complete a short health questionnaire, at no charge and with no obligation. Second, a GPhC-registered prescriber reviews your answers; payment is taken when you place the order, and if the prescriber decides the treatment is not suitable, the order is refunded automatically in full. Third, our registered pharmacy dispenses your pen, with same-day dispatch when ordered by 3pm and free next-day tracked delivery in temperature-controlled, discreet packaging. Saturday delivery is £14.99. All six doses are in stock, supplied through official LillyDirect supply direct from Eli Lilly's UK distribution. You can read more on our Buy Mounjaro page.

Mounjaro is a prescription-only medicine, supplied only after an online consultation reviewed by a GPhC-registered prescriber. It is used alongside a reduced-calorie diet and increased physical activity. Individual results vary. This page is information, not a substitute for medical advice.¹

04 · Drug versus programme

Accountability: the drug versus the programme

Accountability in weight loss comes from the programme around a drug, not from the drug itself. A medicine can reduce appetite, but only a schedule, a person who reviews you and a record you keep make you answerable to a plan. When you compare prescription weight loss drugs for structure, you are really comparing three layers: the dosing rhythm, the clinical follow-up and your own tracking.

The dosing rhythm is built into the product. Mounjaro is a once-weekly injectable made by Eli Lilly, supplied as a multi-dose KwikPen.¹ Choosing a day and sticking to it is a simple anchor: one action a week that you either did or did not do. Wegovy is also once weekly. Liraglutide, including Saxenda and products such as Erly, is a daily injection, which creates more frequent prompts but also more injections to manage.

The clinical follow-up is where services differ most. Some suppliers send a pen and little else. Others, including ours, build in ongoing monthly reviews, dose-titration and follow-up assessments by the prescribing team, plus side-effect support. Repeat orders re-check suitability and there is no auto-shipping, so a new pen only reaches you after a fresh look at how you are doing.

The third layer is yours. A weekly note of your weight, appetite, side effects and meals gives each review something concrete to work from. We offer GLPTrackr, a free companion app for tracking a GLP-1 journey, available on iOS and Android.

So what should you look for? Ask any provider these questions before you start:

• Who reviews my progress, and how often?
• Who adjusts my dose, and on what basis?
• What happens if I have side effects between reviews?
• Is my suitability re-checked each time I reorder?
• Can I reach a person by phone or email during working hours?

We answer those as follows: a GPhC-registered prescriber reviews you, the prescribing team handles monthly reviews and titration, our side-effect support is part of aftercare, repeat orders re-check suitability, and support runs Monday to Friday, 9am to 5pm by email at support@everydaymeds.co.uk, account portal chat or phone on 0333 207 0413.

It is also worth being honest about what structure cannot do. It will not replace a reduced-calorie diet or increased physical activity; the medicine is licensed for use alongside both.¹ Structure works best when the weekly injection prompts a weekly reflection: how hungry was I, what did I eat, how active was I. Used that way, the pen becomes a weekly appointment with your own plan. If you are unsure whether a prescription is even required, our guide on whether you need a prescription for weight loss drugs explains the position.

05 · Weekly rhythm explained

Why a once-weekly pen builds routine

A once-weekly pen builds routine because the whole treatment reduces to one fixed event per week. Tirzepatide, the active ingredient in Mounjaro, is supplied as a pre-filled multi-dose pen in six strengths: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg.¹ The strengths give a natural ladder, and each step is a moment to review how things are going.

Tirzepatide activates two natural gut-hormone receptors at once, GIP and GLP-1. Together these help regulate appetite, slow how quickly the stomach empties and improve the way the body responds to insulin. In practice, most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet.¹ That effect is useful for structure: when hunger is quieter between meals, planned meals are easier to follow.

This dual action distinguishes Mounjaro from single-action GLP-1 medicines such as semaglutide (Wegovy and Ozempic).

Practical ways people build structure around a weekly pen include:

• Choosing a fixed injection day and setting a repeating phone reminder.
• Logging weight at the same time each week, not daily.
• Writing down any side effects so you can discuss them at your monthly review.
• Planning meals for the first days after the injection, when appetite is lowest.

These are habits, not clinical instructions, and they do not change how the medicine is prescribed. For how to inject, follow the pen's own instructions and the patient information leaflet; we include needles, a sharps bin and injection guidance with every order.¹³

Dose-titration is the other piece of rhythm. Your prescriber decides when to move you to a higher strength, and our prescribing team carries out follow-up assessments as part of aftercare. Because each pen lasts a month, the pen change itself becomes a monthly checkpoint. If you want to see how the pen sits within a prescription pathway, our page on weight loss drugs on a Mounjaro prescription in the UK walks through it.

The main limitation of any weekly routine is that it is easy to drift. That is why scheduled reviews matter: they catch missed weeks and unreported side effects early, which a purely self-managed plan would not.

06 · What the trial shows

What SURMOUNT-1 shows about results

In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.² These are trial averages. Individual results vary, and treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.

The trial also reports how many people crossed particular thresholds. At 72 weeks, 85% of participants on 5mg, 89% on 10mg and 91% on 15mg had lost at least 5% of their body weight. Half of participants on 10mg and 57% on 15mg lost at least 20% of their body weight.² Trial averages do not predict your own result, but they show the range of outcomes seen when treatment is followed over a long period.

A worked example makes the percentages concrete. For someone starting at 100 kg, 15% is about 15 kg, 19.5% is about 19.5 kg and 20.9% is about 21 kg. That is straight arithmetic of the trial percentages, not a forecast for any individual, and it says nothing about how quickly a person reaches those figures.

Why does this matter for accountability? Because the 72-week timeframe in the trial is long. Results of this kind come from sustained treatment alongside lifestyle changes, so a plan that keeps you engaged over many months matters more than a fast start. The comparison group, who made lifestyle changes alone, lost on average 3.1%, which shows the gap between lifestyle effort without medication and with it. It does not show that effort is unnecessary; all participants were working on diet and activity.

No licensed medicine is best for everyone; your prescriber decides what suits you. If you want a deeper look at the evidence, see do prescription weight loss drugs work.

What the trial cannot tell you is how you will personally respond. That is the job of your prescriber and your review schedule: to look at your own weight, tolerability and goals and adjust the plan, rather than hold you to an average.

07 · Who is eligible

Who can be prescribed Mounjaro for weight loss

Mounjaro is licensed for weight management in adults with a BMI of 30 or above, or a BMI between 27 and 30 with at least one weight-related condition.¹ Qualifying conditions include high blood pressure, high cholesterol, obstructive sleep apnoea, cardiovascular disease, prediabetes or type 2 diabetes. It must be used alongside a reduced-calorie diet and increased physical activity. A prescriber assesses your BMI, medical history and current medicines before deciding whether it is suitable for you.

That assessment is itself a form of structure. Before you receive a pen, a GPhC-registered prescriber reviews your answers. Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full. The consultation is free, so there is no cost to find out.

The most common questions people have about eligibility are:

• Do I need a particular BMI? The licence sets the thresholds above; your prescriber applies them to your circumstances.
• Does a health condition help me qualify? At a BMI between 27 and 30, at least one weight-related condition is part of the licensed criteria.
• Will my current medicines matter? Yes. The prescriber reviews them, which is why a full and honest health questionnaire matters.

For those wondering how the pathway differs from a GP, our page on getting Mounjaro on prescription for weight loss explains the options. If you also have an underlying condition, such as an underactive thyroid, see prescription weight loss drugs for hypothyroidism and talk to the prescriber about your full history.

Eligibility is also the point at which accountability starts for you. Giving accurate height, weight and medical details is the first act of honesty in the process, and every later review builds on it. If your circumstances change, such as a new diagnosis or a new medicine, tell the prescribing team before your next order. Repeat orders re-check suitability, so there is a natural moment to raise changes.

Finally, remember what the licence says about how treatment should be used: with a reduced-calorie diet and more physical activity. A medicine licensed for use alongside lifestyle change is never a replacement for it.

08 · Weekly or daily dosing

Weekly injections compared with daily ones

Weekly and daily injections create structure in different ways, and neither is automatically better for every person. Mounjaro and Wegovy are once-weekly injections. Liraglutide, supplied as Saxenda and in products such as Erly at a concentration of 6mg per millilitre, is a daily injection.

Wegovy's pens are 0.25mg, 0.5mg, 1mg, 1.7mg and 2.4mg once weekly. Titration steps up after at least 4 weeks and reaches the 2.4mg maintenance dose from week 17; 2.4mg is the licensed maintenance dose for weight management.¹⁸ Mounjaro's ladder has six strengths from 2.5mg to 15mg.¹ Both give you scheduled steps and, with them, scheduled conversations about how you are doing.

A daily injection gives a very frequent prompt. For some people that works well, because the habit is tied to the same time every day. For others it feels burdensome. A weekly injection reduces the number of injections and is easy to forget, so a reminder helps.

One difference worth knowing is what happens if you stop. Tirzepatide has a half-life of about five days, so after a final dose it takes roughly 4–5 weeks to clear the system. There is no way to speed this up, and nothing needs doing while it clears.¹

Each trial studied different people and conditions, and a fair head-to-head needs a head-to-head trial. If you are choosing between products, discuss the evidence for each with your prescriber. Wegovy tablets and other oral options exist; see current Wegovy tablet prices on the relevant product page.

All are prescription medicines with side effects described in their product information, and suitability is decided individually. A prescriber who knows your history is better placed to advise than a general ranking. For other related options, see our guide to prescription weight loss injections.

09 · NHS and private

NHS and private routes to structured treatment

Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first, initially BMI 40+ with four or more qualifying conditions.⁴⁶ Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting.

The NHS route can include structured support, and for some people that is the right place to start. Ask your GP what is available in your area. NHS access to Wegovy runs through specialist weight-management services; ask your GP.

The private route is faster to start but you pay for the medicine. What you get for that depends on the provider, so check the service as well as the price. With us, you get a free consultation reviewed by a GPhC-registered prescriber, ongoing monthly reviews, dose-titration and follow-up assessments, side-effect support, and repeat orders that re-check suitability. A pharmacy registered with the GPhC can be verified on the public register; ours is registration 9012878.¹²

How do you decide? Consider these points:

• Eligibility. If you meet NHS criteria in your area and are happy to wait, ask your GP about the pathway.
• Timing. If access is not yet open to you, private treatment starts after the consultation and prescriber review.
• Support. Whichever route, find out how often you are reviewed and who adjusts your dose.
• Cost. Private treatment is paid for monthly. With us there are no subscriptions, and Klarna and pay-monthly options are available.

It is not either/or in a rigid way. Some people begin privately and later move to NHS care when they become eligible; speak to your GP if you are considering that, and tell the prescribing team about any plans. Private treatment is an option for adults who meet the licensed criteria and want to start without waiting for NHS access to reach them.

Another thing to check on any private route is whether the supply is genuine. Our Mounjaro comes through official LillyDirect supply, direct from Eli Lilly's UK distribution, as genuine KwikPens.

10 · Reviews and aftercare

Monthly reviews, aftercare and tracking

Monthly reviews are the accountability feature that matters most, because they put a clinician in front of your progress at a fixed interval. Our aftercare includes ongoing monthly reviews, dose-titration and follow-up assessments by the prescribing team, and side-effect support. Because each pen lasts four weeks, the review rhythm lines up with the reorder rhythm.

What should a review cover? A useful one looks at the following:

• How your weight and measurements have changed since last time.
• How your appetite and eating pattern feel at the current dose.
• Any side effects, how long they lasted and how they affected your day.
• Whether to stay at the current strength or discuss moving up.
• Any new medicines, conditions or changes in circumstances.

Come prepared. The more specific your notes, the more useful the conversation. This is where tracking pays off. GLPTrackr is our free companion app for tracking a GLP-1 journey on iOS and Android, so your weekly entries are ready when review time comes.

Side effects deserve a plain mention. The most common side effects, affecting more than 1 in 10 people, are nausea, diarrhoea, vomiting, constipation and abdominal discomfort; they are most likely when starting treatment or moving up a dose, and for most people they ease within days to a few weeks.¹³ If you notice a new symptom, speak to your prescriber, and you can report suspected side effects through the MHRA Yellow Card scheme.¹⁹ A symptom that is not on the leaflet's list is not a listed side effect; tell your prescriber about any new or lasting symptom.

Support is practical and human. Our team is available Monday to Friday, 9am to 5pm, by email at support@everydaymeds.co.uk, through account portal chat or by phone on 0333 207 0413. Delivery is free, next-day and tracked, in discreet, temperature-controlled packaging, with same-day dispatch when ordered by 3pm.

The main limit on structure is you. A review can only respond to what you share, and a plan only works if you attend to it. Treat each review as a real checkpoint rather than a formality.

11 · Planning the cost

Planning the cost over a year

Planning the cost means thinking in pens, because each pen is four weeks of treatment. If you step up after 4 weeks on each dose, your first four pens (2.5mg to 10mg) cost £959.96 at standard prices. A first year of 52 weeks and 13 pens costs £2,711.88 if you settle at 5mg, and up to £3,599.88 if you settle at 15mg. These are standard prices before discounts: a new customer's first order is £40 less with code FIRST40, and every later order is £25 less (code DOSE25).

If you settle at another strength, work from that dose's monthly price: £279.99 for 7.5mg, £290.99 for 10mg or £319.99 for 12.5mg, each per 4-week pen. At the extremes, 5mg costs £218.99 and 15mg costs £329.99 per pen. The weekly equivalents are £54.75 at 5mg and £82.50 at 15mg, which can be a useful way to compare with other weekly spending.

How do these compare with the market? Across the UK pharmacies we track, Mounjaro pens range from £143.96 to £339.00 per month depending on dose and provider, as checked 10 October 2026. The cheapest and dearest 2.5mg starting pens run from £143.96 to £179.99, and for the same dose the gap between providers ranges from £27 to £41. Boots' Mounjaro dose prices run from £179.00 to £339.00. Price is only one part of the decision; what the service includes is the other.

Costs worth budgeting for beyond the pen are small and mostly absent: the consultation is free, standard delivery is free and next-day, and needles, a sharps bin and injection guidance come with every order. Saturday delivery is £14.99 if you want it. Refunds are straightforward where a consultation is declined, with automatic full refunds. Dispensed prescription medicines cannot be returned except where faulty, damaged or the wrong item, which you must report within 3 days; refunds take 5–10 working days.

Before you commit, think about the whole picture: how long you expect to be on treatment, what you would do if you stopped, and what support you need.

12 · Safety and genuine supply

Safety, genuine supply and when to stop

Safety starts with getting genuine medicine from a regulated pharmacy after a proper consultation. Mounjaro is a prescription-only medicine, supplied only after an online consultation reviewed by a GPhC-registered prescriber.¹ Be wary of anyone offering to supply without a consultation or prescription, or selling pens at prices that look too good to be true. The MHRA publishes counterfeit medicine alerts and runs the Yellow Card scheme for reporting suspected side effects and suspect products.⁷ You can check any pharmacy on the GPhC public register.¹²

Our supply is official LillyDirect, direct from Eli Lilly's UK distribution, with genuine KwikPens and all six doses stocked from 2.5mg to 15mg. Keep pens in a fridge at 2–8°C and never freeze them; once in use, a pen can be kept out of the fridge at a temperature not above 30°C for up to 30 days after first use and must then be thrown away, and the pen's own instructions cover how to use it.¹³

Two safety topics come up often. First, contraception: Mounjaro slows stomach emptying, which can reduce how well oral contraceptive pills are absorbed.⁷ The SmPC advises switching to a non-oral method, or adding a barrier method (such as condoms), for 4 weeks after starting Mounjaro and for 4 weeks after each dose increase.¹ Second, other medicines: if you take insulin or sulfonylureas, doses may need adjusting because of the risk of low blood sugar, so tell your prescriber about them. Neither is a reason to avoid asking; they are reasons to be open in your consultation.

Mood is another topic that readers raise. Regulators have looked specifically at whether GLP-1 medicines are linked to low mood or suicidal thoughts: the EMA's safety committee reviewed the evidence and concluded in 2024 that it does not support a causal link, and the MHRA keeps this under continuous review.¹⁷ Tell your prescriber about any history of depression, and seek help promptly if your mood drops or you have distressing thoughts during treatment.

If you have thoughts of harming yourself or ending your life, get help straight away. Call 999 or go to A&E if you are in immediate danger. In England you can call NHS 111 and choose the mental health option, any time. You can also call Samaritans free on 116 123, day or night. Tell your prescriber about any change in your mood while taking Mounjaro.

If you decide to stop, plan it with your prescriber, with diet and activity habits ready to carry the load. Tirzepatide has a half-life of about five days, so after a final dose it takes roughly 4–5 weeks to clear the system; nothing needs doing while it clears.¹

You may also see the phrase poor man's Ozempic. It is marketing language used for low-cost supplements. These are available cheaply without assessment and come with no clinical oversight. Their dosing is not standardised and we give no efficacy figures for them. If you are weighing them up, read our page on the best non prescription weight loss drugs and speak to a pharmacist or prescriber. Dramatic weight-loss claims on supplement packaging should be treated with caution, and a prescriber who reviews you provides what a supplement cannot: a clinical check on suitability and follow-up.

13 · Serious side effects

Serious side effects: when to get help straight away

Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.¹